West Kent Interface Adult Formulary
MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Coronavirus

Drug Safety Update

November 2023: Nirmatrelvir, ritonavir (Paxlovid▼): be alert to the risk of drug interactions with ritonavir

NICE Guidance

NG191: COVID-19 rapid guideline: managing COVID-19, March 2021 (last updated May 2024)

TA878: Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19, March 2023 (last updated March 2024)

TA971: Remdesivir and tixagevimab plus cilgavimab for treating COVID-19, May 2024 (Please note tixagevimab plus cilgavimab is not recommended)